2020 annual financial data
BioNexus Gene Lab 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was 4.85%.
Operating income was 1,273,822 USD and net income was 1,094,098 USD.
Operating cash flow was 552,680 USD.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,390,440 USD
- Operating income
- 1,273,822 USD
- Net income
- 1,094,098 USD
- Operating cash flow
- 552,680 USD